Selected article for: "hepatitis virus and large proportion"

Author: Frese, Michael; Dazert, Eva
Title: Interferon-Induced Effector Proteins and Hepatitis C Virus Replication
  • Cord-id: wc3i54fc
  • Document date: 2008_1_1
  • ID: wc3i54fc
    Snippet: Hepatitis C virus (HCV) is a small, enveloped RNA virus that is often capable of establishing a persistent infection, which may lead to chronic liver disease, cirrhosis, hepatocellular carcinoma, and eventually death. For more than 20 years, hepatitis C patients have been treated with interferon-alpha (IFN-α). Current treatment usually consists of polyethylene glycol-conjugated IFN-α that is combined with ribavirin, but even the most advanced IFN-based therapies are still ineffective in elimin
    Document: Hepatitis C virus (HCV) is a small, enveloped RNA virus that is often capable of establishing a persistent infection, which may lead to chronic liver disease, cirrhosis, hepatocellular carcinoma, and eventually death. For more than 20 years, hepatitis C patients have been treated with interferon-alpha (IFN-α). Current treatment usually consists of polyethylene glycol-conjugated IFN-α that is combined with ribavirin, but even the most advanced IFN-based therapies are still ineffective in eliminating the virus from a large proportion of individuals. Therefore, a better understanding of the IFN-induced innate immune response is urgently needed. By using selectable self-replicating RNAs (replicons) and, more recently, recombinant full-length genomes, many groups have tried to elucidate the mechanism(s) by which IFNs inhibit HCV replication. This chapter attempts to summarize the current state of knowledge in this interesting field of HCV research.

    Search related documents:
    Co phrase search for related documents
    • activation dimerization and adaptor protein: 1
    • activation factor and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activation factor and adapter protein: 1, 2
    • activation factor and adaptive immune response: 1, 2, 3
    • activation factor and adaptor protein: 1, 2, 3, 4
    • activation need and acute respiratory coronavirus: 1
    • activation need and adaptive immune response: 1
    • activation site and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • activation site and adaptive immune response: 1
    • activator signal transducer and acute respiratory coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • activator signal transducer and adaptive immune response: 1, 2, 3, 4
    • acute respiratory coronavirus and adapter protein: 1
    • acute respiratory coronavirus and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory coronavirus and adaptive mutation: 1, 2, 3, 4, 5
    • acute respiratory coronavirus and adaptor protein: 1, 2, 3, 4